SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-036162
Filing Date
2021-07-08
Accepted
2021-07-08 16:05:36
Documents
13
Period of Report
2021-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea143919-8k_augmedix.htm   iXBRL 8-K 34133
2 AUGMEDIX, INC. 2020 EQUITY INCENTIVE PLAN, AS AMENDED AND RESTATED EFFECTIVE JUL ea143919ex10-1_augmedix.htm EX-10.1 141995
  Complete submission text file 0001213900-21-036162.txt   381094

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE augx-20210701.xsd EX-101.SCH 3033
4 XBRL LABEL FILE augx-20210701_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE augx-20210701_pre.xml EX-101.PRE 22364
6 EXTRACTED XBRL INSTANCE DOCUMENT ea143919-8k_augmedix_htm.xml XML 3389
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56036 | Film No.: 211080242
SIC: 7389 Services-Business Services, NEC